- Home
- AMBP vs GPCR Comparison
AMBP vs GPCR Comparison
Compare AMBP & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBP
- GPCR
- Stock Information
- Founded
- AMBP 2021
- GPCR 2016
- Country
- AMBP Luxembourg
- GPCR United States
- Employees
- AMBP N/A
- GPCR N/A
- Industry
- AMBP Containers/Packaging
- GPCR
- Sector
- AMBP Industrials
- GPCR
- Exchange
- AMBP Nasdaq
- GPCR Nasdaq
- Market Cap
- AMBP 1.9B
- GPCR 1.1B
- IPO Year
- AMBP N/A
- GPCR 2023
- Fundamental
- Price
- AMBP $3.62
- GPCR $26.82
- Analyst Decision
- AMBP Buy
- GPCR Strong Buy
- Analyst Count
- AMBP 4
- GPCR 9
- Target Price
- AMBP $3.30
- GPCR $78.13
- AVG Volume (30 Days)
- AMBP 2.3M
- GPCR 1.2M
- Earning Date
- AMBP 04-24-2025
- GPCR 05-16-2025
- Dividend Yield
- AMBP 11.06%
- GPCR N/A
- EPS Growth
- AMBP N/A
- GPCR N/A
- EPS
- AMBP N/A
- GPCR N/A
- Revenue
- AMBP $5,035,000,000.00
- GPCR N/A
- Revenue This Year
- AMBP $4.65
- GPCR N/A
- Revenue Next Year
- AMBP $2.39
- GPCR N/A
- P/E Ratio
- AMBP N/A
- GPCR N/A
- Revenue Growth
- AMBP 4.42
- GPCR N/A
- 52 Week Low
- AMBP $2.50
- GPCR $13.22
- 52 Week High
- AMBP $4.26
- GPCR $62.74
- Technical
- Relative Strength Index (RSI)
- AMBP 65.25
- GPCR 65.53
- Support Level
- AMBP $3.47
- GPCR $25.06
- Resistance Level
- AMBP $3.77
- GPCR $27.78
- Average True Range (ATR)
- AMBP 0.15
- GPCR 1.76
- MACD
- AMBP 0.02
- GPCR 0.37
- Stochastic Oscillator
- AMBP 82.98
- GPCR 75.75
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.